Medicus pharma ltd. announces collaboration with the gorlin syndrome alliance to pursue compassionate use pathway for skinject™ in patients with gorlin syndrome

Gorlin syndrome, also known as nevoid basal cell carcinoma syndrome, is a rare inherited genetic disorder affecting 1 in 31,000 people worldwide that can develop 500-1000 basal cell carcinoma (bcc) lesions over lifetime gorlin syndrome, also known as nevoid basal cell carcinoma syndrome, is a rare inherited genetic disorder affecting 1 in 31,000 people worldwide that can develop 500-1000 basal cell carcinoma (bcc) lesions over lifetime
BCC Ratings Summary
BCC Quant Ranking